14-Jan-2026 10:52 AM CST - Yahoo Finance TD Cowen is Bullish on Colgate-Palmolive Company (CL) Colgate-Palmolive Company (NYSE:CL) is among the 7 Best Beauty Stocks to Buy Right Now. On January 8, 2026, TheFly reported that TD Cowen reduced Colgate-Palmolive Company (NYSE:CL)'s price target from $90 to $86 and maintained a Buy rating.
9-Jan-2026 8:53 AM CST - Yahoo Finance Is Colgate-Palmolive (CL) Pricing Reflect Its Consumer Staples Resilience? If you are wondering whether Colgate-Palmolive at around US$80.87 is a fair deal or a stretch, you are in the right place to size up what you are really paying for. The stock has returned 2.3% over the last 7 days,
6-Jan-2026 3:58 PM CST - Seeking Alpha Piper Sandler sees Colgate-Palmolive growth accelerating in 2026 Piper Sandler analyst Michael Lavery upgraded Colgate-Palmolive (CL) to Overweight from Neutral and set an $88 price target that assumes 14% upside from Tuesday's closing price to reflect more moderate inflationary pressures,
5-Jan-2026 9:27 PM CST - Yahoo Finance Colgate-Palmolive (CL) Remains Overweight as JPMorgan Sees Headwinds Easing in 2026 Colgate-Palmolive Company (NYSE:CL) is included among the 13 Best January Dividend Stocks to Invest in. On December 18, JPMorgan raised its price target on Colgate-Palmolive Company (NYSE:CL) to $88 from $87 and kept an Overweight rating as part of its 2026 outlook.
2-Jan-2026 7:14 PM CST - Seeking Alpha Colgate-Palmolive: Consistent Long-Term Execution Makes It Attractive Colgate-Palmolive (CL) is a Dividend King with strong dividend safety, high margins, and consistent long-term execution, currently trading at a reasonable 21.6x earnings. CL's science-based innovation and focus on high-growth categories and incremental product improvements, reinforcing its wide moat and market share, especially in oral care.
30-Dec-2025 2:59 PM CST - Yahoo Finance Colgate-Palmolive (CL) Target Raised as Analysts Split on 2026 Staples Outlook Colgate-Palmolive Company (NYSE:CL) is included among the 14 Best Dividend Aristocrats to Invest in Heading into 2026. On December 19, BofA raised its price target on Colgate-Palmolive Company (NYSE:CL) to $90 from $88 and kept a Buy rating.
Latest CL Trades by Congress Members
6-OCT-2025 - Rick Larsen, WA (District 2) sold between $1,001 and $15,000.
14-Jan-2026 10:52 AM CST - Yahoo Finance TD Cowen is Bullish on Colgate-Palmolive Company (CL) Colgate-Palmolive Company (NYSE:CL) is among the 7 Best Beauty Stocks to Buy Right Now. On January 8, 2026, TheFly reported that TD Cowen reduced Colgate-Palmolive Company (NYSE:CL)'s price target from $90 to $86 and maintained a Buy rating.
9-Jan-2026 8:53 AM CST - Yahoo Finance Is Colgate-Palmolive (CL) Pricing Reflect Its Consumer Staples Resilience? If you are wondering whether Colgate-Palmolive at around US$80.87 is a fair deal or a stretch, you are in the right place to size up what you are really paying for. The stock has returned 2.3% over the last 7 days,
6-Jan-2026 3:58 PM CST - Seeking Alpha Piper Sandler sees Colgate-Palmolive growth accelerating in 2026 Piper Sandler analyst Michael Lavery upgraded Colgate-Palmolive (CL) to Overweight from Neutral and set an $88 price target that assumes 14% upside from Tuesday's closing price to reflect more moderate inflationary pressures,
5-Jan-2026 9:27 PM CST - Yahoo Finance Colgate-Palmolive (CL) Remains Overweight as JPMorgan Sees Headwinds Easing in 2026 Colgate-Palmolive Company (NYSE:CL) is included among the 13 Best January Dividend Stocks to Invest in. On December 18, JPMorgan raised its price target on Colgate-Palmolive Company (NYSE:CL) to $88 from $87 and kept an Overweight rating as part of its 2026 outlook.
2-Jan-2026 7:14 PM CST - Seeking Alpha Colgate-Palmolive: Consistent Long-Term Execution Makes It Attractive Colgate-Palmolive (CL) is a Dividend King with strong dividend safety, high margins, and consistent long-term execution, currently trading at a reasonable 21.6x earnings. CL's science-based innovation and focus on high-growth categories and incremental product improvements, reinforcing its wide moat and market share, especially in oral care.
30-Dec-2025 2:59 PM CST - Yahoo Finance Colgate-Palmolive (CL) Target Raised as Analysts Split on 2026 Staples Outlook Colgate-Palmolive Company (NYSE:CL) is included among the 14 Best Dividend Aristocrats to Invest in Heading into 2026. On December 19, BofA raised its price target on Colgate-Palmolive Company (NYSE:CL) to $90 from $88 and kept a Buy rating.
